Bnp Paribas Asset Management Holding S.A. Novo Cure LTD Transaction History

Bnp Paribas Asset Management Holding S.A.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 08, 2023	SELL	$40.29 - $82.51 $3.88 Million - $7.95 Million	-96,306 Reduced 89.67%	11,090 $460,000
Q1 2023 May 08, 2023	SELL	$56.44 - $118.81 $183,204 - $385,657	-3,246 Reduced 2.93%	107,396 $6.46 Million
Q4 2022 Feb 09, 2023	SELL	$63.98 - $85.37 $280,616 - $374,432	-4,386 Reduced 3.81%	110,642 $8.12 Million
Q3 2022 Nov 10, 2022	SELL	$67.99 - $89.57 $104,432 - $137,579	-1,536 Reduced 1.32%	115,028 $8.74 Million
Q2 2022 Aug 04, 2022	BUY	$56.6 - $89.9 $6.44 Million - $10.2 Million	113,866 Added 4220.39%	116,564 $8.1 Million
Q1 2022 May 12, 2022	BUY	$60.15 - $84.52 $162,284 - $228,034	2,698 New	2,698 $224,000

262

77M

1.17M

318K

Ticker NVCR
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 104,950,000
Market Cap $1.86B
Description
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...

Get notified when there are updates to the investment portfolio of Bnp Paribas Asset Management Holding S.A., based on Form 13F filings with the SEC.

Stay updated on Bnp Paribas Asset Management Holding S.A. with notifications on news.